GoAI
Get started
Fureasu Co.,Ltd. logo

Fureasu Co.,Ltd.

7062.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥720

+¥8.00 · +1.12%

Aug 24, 11:30 AM JST

7062.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Fureasu Co.,Ltd. is a Japanese company specializing in therapeutic massage services, massage franchise operations, and a diverse range of care solutions. Its therapeutic offerings encompass in-home acupuncture, moxibustion treatments, on-site corporate massage, and specialized support tailored for individuals with visual impairments. Beyond its bodywork segment, the company delivers a broad spectrum of in-home and institutional care services. This includes comprehensive small-scale multi-functional home nursing, domiciliary care visits, day-care transportation, and overnight respite programs. Fureasu also operates home-visit nursing services and manages medical care facilities, further providing personal care assistance for daily living activities like eating, excretion, and bathing. Established in 2000, Fureasu Co.,Ltd. is headquartered in Tokyo, Japan.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Taku Sawanobori
Listed since
Mar 28, 2019
Employees
761

Market position

Day range

Current ¥720

52-week range

Current ¥720

Open
¥721
Previous close
¥712
Volume
2.4K
0.47× average
Average volume
5.12K
Average daily volume
Market cap
1.88B JPY
Beta
0.41
Market reference 1
50-day average
¥764.42
-5.81% below average
200-day average
¥810.03
-11.11% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.62B JPY
P/E (TTM)
3.11×
P/B (TTM)
0.86×
P/S (TTM)
0.27×
EV / EBITDA
5.43×
Earnings yield
24.22%
Free cash flow yield
26.87%
Dividend yield
1.47%

Profitability & efficiency

Gross margin
47.98%
Operating margin
5.24%
Net margin
8.82%
Return on equity
23.34%
Return on assets
9.44%
Return on invested capital
5.04%

Financial health

Debt / equity
0.93×
Current ratio
2.12×
Altman Z-score
3.08
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends55%34%13%-9%Gross margin, FY2021: 49.80%Gross margin, FY2022: 48.82%Gross margin, FY2023: 47.19%Gross margin, FY2024: 42.15%Gross margin, FY2025: 45.25%Operating margin, FY2021: 4.41%Operating margin, FY2022: 0.32%Operating margin, FY2023: 1.94%Operating margin, FY2024: -1.39%Operating margin, FY2025: 3.84%Net margin, FY2021: 3.54%Net margin, FY2022: 0.69%Net margin, FY2023: 1.02%Net margin, FY2024: -3.23%Net margin, FY2025: 6.66%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 49.80%. Gross margin FY2022 48.82%. Gross margin FY2023 47.19%. Gross margin FY2024 42.15%. Gross margin FY2025 45.25%. Operating margin FY2021 4.41%. Operating margin FY2022 0.32%. Operating margin FY2023 1.94%. Operating margin FY2024 -1.39%. Operating margin FY2025 3.84%. Net margin FY2021 3.54%. Net margin FY2022 0.69%. Net margin FY2023 1.02%. Net margin FY2024 -3.23%. Net margin FY2025 6.66%.

Income trends

Revenue

7.64B JPY+0.72%

Operating income

293.22M JPY+398.32M JPY

Net income

508.92M JPY+753.46M JPY
Income trends across reported periods8.43B JPY5.27B JPY2.12B JPY−1.03B JPYRevenue, FY2021: 4.17B JPYRevenue, FY2022: 4.58B JPYRevenue, FY2023: 5.71B JPYRevenue, FY2024: 7.58B JPYRevenue, FY2025: 7.64B JPYOperating income, FY2021: 184.25M JPYOperating income, FY2022: 14.8M JPYOperating income, FY2023: 110.6M JPYOperating income, FY2024: −105.1M JPYOperating income, FY2025: 293.22M JPYNet income, FY2021: 147.85M JPYNet income, FY2022: 31.59M JPYNet income, FY2023: 58.31M JPYNet income, FY2024: −244.55M JPYNet income, FY2025: 508.92M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 4.17B JPY. Revenue FY2022 4.58B JPY. Revenue FY2023 5.71B JPY. Revenue FY2024 7.58B JPY. Revenue FY2025 7.64B JPY. Operating income FY2021 184.25M JPY. Operating income FY2022 14.8M JPY. Operating income FY2023 110.6M JPY. Operating income FY2024 −105.1M JPY. Operating income FY2025 293.22M JPY. Net income FY2021 147.85M JPY. Net income FY2022 31.59M JPY. Net income FY2023 58.31M JPY. Net income FY2024 −244.55M JPY. Net income FY2025 508.92M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue7.64B JPY7.58B JPY5.71B JPY4.58B JPY4.17B JPY
Cost of goods sold4.18B JPY4.39B JPY3.02B JPY2.35B JPY2.1B JPY
Gross profit3.46B JPY3.2B JPY2.69B JPY2.24B JPY2.08B JPY
Selling, general, and administrative3.16B JPY3.3B JPY2.48B JPY2.15B JPY1.83B JPY
Operating expenses3.16B JPY3.3B JPY2.58B JPY2.22B JPY1.89B JPY
Interest expense100.13M JPY102.28M JPY38.93M JPY13.55M JPY6.54M JPY
Depreciation and amortization189.5M JPY239.74M JPY156.84M JPY97.37M JPY67.5M JPY
Operating income293.22M JPY−105.1M JPY110.6M JPY14.8M JPY184.25M JPY
Net income508.92M JPY−244.55M JPY58.31M JPY31.59M JPY147.85M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
9.39

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates148.876.143.47-69.19Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual -3.78, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual -54.16, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual -21.56, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 14, 2025: actual -27.73, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 133.77, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 44.23, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 45.94, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual 9.39, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates2.49B2.12B1.75B1.38BQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 1.92B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual 1.99B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 2.03B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 14, 2025: actual 2.39B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 2.2B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 1.57B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 1.47B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual 1.61B JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥10.57

2024 complete year0.0% since 2022

2026 partial: ¥10.57

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Mar 30, 2027

¥10.57

Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥10.57

Annual

Record Mar 31, 2026 · Payment Jun 29, 2026

Dividend

Ex-dividend Mar 28, 2024

¥10.57

Annual

Record Mar 31, 2024 · Payment Jun 26, 2024

Dividend

Ex-dividend Mar 30, 2023

¥10.57

Annual

Record Mar 31, 2023 · Payment Jun 28, 2023

Dividend

Ex-dividend Mar 30, 2022

¥10.57

Annual

Record Mar 31, 2022 · Payment Jun 29, 2022

7062.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,008

-0.04%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,799

+0.61%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,990

+0.38%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,392.5

+0.23%

Continue in GoAI

Research 7062.T

research.disclaimer